# Implications of host sex on liver metabolism during Schistosoma mansoni Infection

**Authors:** Verena von Bülow, Anne Baier, Nicola Buss, Frederik Stettler, Christoph G. Grevelding, Martin Roderfeld, Elke Roeb

PMC · DOI: 10.3389/fcimb.2026.1750683 · Frontiers in Cellular and Infection Microbiology · 2026-02-03

## TL;DR

This paper explores how host sex affects liver metabolism during Schistosoma mansoni infection, potentially influencing disease progression and organ damage.

## Contribution

The paper highlights new insights into sex-specific metabolic changes in the liver during S. mansoni infection, particularly focusing on autophagy.

## Key findings

- Host sex influences liver metabolism during S. mansoni infection.
- Sex-specific differences in autophagy may contribute to liver damage in infected hosts.

## Abstract

Various studies suggest that host gender is a disease-determining factor in schistosomiasis. Men have a higher prevalence in endemic areas and show a greater degree of liver damage in chronic infection with Schistosoma mansoni. It is currently unclear whether this is only due to socioeconomic causes, such as the working environment and behavior. It was recently suggested that molecular biological differences in the infected host could also contribute to the disease. Current studies in model systems suggest that hormonal influences affect liver metabolism during infection with S. mansoni. In particular, a metabolic recycling process in the cell, known as autophagy, could be altered in a sex-specific manner and influence the course of the disease. It is suspected that the differences in metabolism in the liver of S. mansoni-infected hosts could contribute to cell stress and thus to organ damage on the molecular level. This article summarizes and discusses known and new aspects of the gender-specific influence on liver metabolism in S. mansoni infection.

## Linked entities

- **Diseases:** schistosomiasis (MONDO:0015254)
- **Species:** Schistosoma mansoni (taxon 6183)

## Full-text entities

- **Genes:** PKM (pyruvate kinase M1/2) [NCBI Gene 5315] {aka CTHBP, HEL-S-30, OIP3, PK3, PKM2, TCB}, ATG7 (autophagy related 7) [NCBI Gene 10533] {aka APG7-LIKE, APG7L, GSA7, SCAR31}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, MT2A (metallothionein 2A) [NCBI Gene 4502] {aka MT-2, MT-II, MT2}, PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial) [NCBI Gene 5106] {aka PEPCK, PEPCK-M, PEPCK2, mtPCK2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ATG12 (autophagy related 12) [NCBI Gene 9140] {aka APG12, APG12L, FBR93, HAPG12}, acetyl-CoA carboxylase [NCBI Gene 8348315], CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, H6PD (hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase) [NCBI Gene 9563] {aka CORTRD1, G6PDH, GDH, H6PDH}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, ARG1 (arginase 1) [NCBI Gene 383], APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, GCK (glucokinase) [NCBI Gene 2645] {aka FGQTL3, GK, GLK, HHF3, HK4, HKIV}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, ACSS2 (acyl-CoA synthetase short chain family member 2) [NCBI Gene 55902] {aka ACAS2, ACECS, ACS, ACSA, AceCS1, dJ1161H23.1}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971] {aka BAR, FXR, HRR-1, HRR1, PFIC5, RIP14}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, glycogen synthase [NCBI Gene 8350952], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}
- **Diseases:** cancer (MESH:D009369), Schistosomiasis (MESH:D012552), diabetes (MESH:D003920), hepatosplenomegaly (MESH:C535727), hepatitis C (MESH:D019698), hepatitis B (MESH:D006509), Liver fibrosis (MESH:D008103), metabolic disturbances (MESH:D024821), Periportal fibrosis (MESH:D005355), Chronic inflammation (MESH:D007249), granulomatous (MESH:D013968), S. mansoni infection (MESH:D012555), metabolic (MESH:D008659), hypoxic (MESH:D002534), obese (MESH:D009765), carcinogenesis (MESH:D063646), chronic liver damage (MESH:D056487), neglected tropical disease (MESH:D058069), infected (MESH:D007239), toxicity (MESH:D064420), portal hypertension (MESH:D006975), atherosclerosis (MESH:D050197), viral infections (MESH:D014777), hepatomegaly (MESH:D006529), HCC (MESH:D006528), chronic (MESH:D002908), Bs (MESH:D002836), schistosome infection (MESH:D020818), organ damage (MESH:D000092124), granuloma (MESH:D006099), parasite infection (MESH:D010272), type 1 diabetes mellitus (MESH:D003922), hepatic injury (MESH:D056486)
- **Chemicals:** bromophenol blue (MESH:D001978), pentose phosphate (MESH:D010428), oxygen (MESH:D010100), zinc (MESH:D015032), acid (MESH:D000143), SDS (MESH:D012967), DTT (MESH:D004229), blood sugar (MESH:D001786), PZQ (MESH:D011223), Testosterone (MESH:D013739), glycogen (MESH:D006003), amino acid (MESH:D000596), NADPH (MESH:D009249), carbohydrate (MESH:D002241), fatty acid (MESH:D005227), MDA (MESH:D008315), GSSG (MESH:D019803), bile acid (MESH:D001647), Sirius red (-), glycerol (MESH:D005990), PVDF (MESH:C024865), alcohol (MESH:D000438), ROS (MESH:D017382), chloroquine (MESH:D002738), heavy metal (MESH:D019216), glucose (MESH:D005947), GSH (MESH:D005978), ATP (MESH:D000255), Lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Biomphalaria glabrata (bloodfluke planorb, species) [taxon 6526], Schistosoma haematobium (species) [taxon 6185], Schistosoma japonicum (species) [taxon 6182], hepatitis C virus [taxon 11103], Hepatitis B virus (no rank) [taxon 10407], Schistosoma mansoni (species) [taxon 6183], Homo sapiens (human, species) [taxon 9606], Cricetinae (hamsters, subfamily) [taxon 10026], Mesocricetus auratus (golden hamster, species) [taxon 10036], S. japonicum [taxon 349478]
- **Cell lines:** c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12909591/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909591/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12909591/full.md

---
Source: https://tomesphere.com/paper/PMC12909591